Red Cell Distribution Width Predicts Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome

Angiology

Volumn 66, Issue 5, 2015, Pages 433-440

  Kurtul, Alparslan ^a   Yarlioglues, Mikail ^a   Murat, Sani Namik ^a   Demircelik, Muhammed Bora ^b   Acikgoz, Sadik Kadri ^a   Ergun, Gokhan ^a   Duran, Mustafa ^a   Cetin, Mustafa ^a   Ornek, Ender ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b TURGUT OZAL UNIVERSITY   (Turkey)

Author keywords

acute coronary syndrome; contrast induced nephropathy; percutaneous coronary intervention; red cell distribution width

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TIROFIBAN; AUTACOID; BIOLOGICAL MARKER; CONTRAST MEDIUM;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BARE METAL STENT; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEVICE THERAPY; DIAGNOSTIC TEST ACCURACY STUDY; DIURETIC THERAPY; DRUG ELUTING CORONARY STENT; ERYTHROCYTE FUNCTION AND CHARACTERISTICS; ERYTHROCYTE VOLUME; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEPARINIZATION; HUMAN; INDEPENDENT VARIABLE; INTERVENTION STUDY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; RED CELL DISTRIBUTION WIDTH; REFERENCE VALUE; RISK FACTOR; SINGLE DRUG DOSE; ADVERSE EFFECTS; AGED; ANGIOCARDIOGRAPHY; BLOOD; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; DIAGNOSTIC USE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; INTERVENTIONAL RADIOLOGY; KIDNEY DISEASES; MEAN CORPUSCULAR VOLUME; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RADIOGRAPHY; RISK; STATISTICAL MODEL; TREATMENT OUTCOME; UPREGULATION;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; ERYTHROCYTE INDICES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; RADIOGRAPHY, INTERVENTIONAL; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME; UP-REGULATION; VENTRICULAR FUNCTION, LEFT;

EID: 84928028558     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714535238     Document Type: Article

References (55)

1. Goldfarb S, McCullough PA, McDermott J, Gay SB. Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc. 2009 ; 84 (2). 170-179
2. Finn WF. The clinical and renal consequences of contrast-induced nephropathy. Nephrol Dial Transplant. 2006 ; 21 (6). i2 - i10
3. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008 ; 51 (15). 1419-1428
4. Recio-Mayoral A, Chaparro M, Prado B, et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol. 2007 ; 49 (12). 1283-1288
5. Lazaros G, Tsiachris D, Tousoulis D, et al. In-hospital worsening renal function is an independent predictor of one-year mortality in patients with acute myocardial infarction. Int J Cardiol. 2012 ; 155 (1). 97-101
6. Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004 ; 93 (12). 1515-1519
7. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 ; 44 (7). 1393-1399
8. Senoo T, Motohiro M, Kamihata H, et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2010 ; 105 (5). 624-628
9. McCullough PA, Stacul F, Becker CR, et al. Contrast-Induced Nephropathy (CIN) consensus working panel: executive summary. Rev Cardiovasc Med. 2006 ; 7 (4). 177-197
10. Heyman SN, Rosen S, Khamaisi M, Idee JM, Rosenberger C. Hypoxia, oxidative stress and the pathophysiology of contrast-media-induced nephropathy. In: Miyata T, Eckardt KW, Nangaku M, eds. Oxidative Stress in Basic Research and Clinical Practice: Studies on Renal Disorders. New York: Humana Press/Springer Science; 2011:229-256.
11. Heyman SN, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol. 2008 ; 3 (1). 288-296
12. Heyman SN, Rosen S, Khamaisi M, Idée JM, Rosenberger C. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Investigative Radiology. 2010 ; 45 (4). 188-195
13. Lin CK, Lin JS, Chen SY, Jiang ML, Chiu CF. Comparison of hemoglobin and red blood cell distribution width in the differential diagnosis of microcytic anemia. Arch Pathol Lab Med. 1992 ; 116 (10). 1030-1032
14. Aung N, Ling HZ, Cheng AS, et al. Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. Int J Cardiol. 2013 ; 168 (3). 1997-2002
15. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med. 1991;9(suppl 1):71-74.
16. Ferrucci L, Guralnik JM, Woodman RC, et al. Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med. 2005 ; 118 (11). 1288
17. Semba RD, Patel KV, Ferrucci L, et al. Serum antioxidants and inflammation predict red cell distribution width in older women: the Women's Health and Aging Study I. Clin Nutr. 2010 ; 29 (5). 600-604
18. Felker GM, Allen LA, Pocock SJ, et al. CHARM Investigators. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007 ; 50 (1). 40-47
19. Pascual-Figal DA, Bonaque JC, Redondo B, et al. Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail. 2009 ; 11 (9). 840-846
20. Núñez J, Núñez E, Rizopoulos D, et al. Red blood cell distribution width is longitudinally associated with mortality and anemia in heart failure patients. Circ J. 2014 ; 78 (2). 410-418
21. Kalay N, Aytekin M, Kaya MG, et al. The relationship between inflammation and slow coronary flow: increased red cell distribution width and serum uric acid levels. Turk Kardiyol Dern Ars. 2011 ; 39 (6). 463-468
22. Tonelli M, Sacks F, Arnold M, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008 ; 117 (2). 163-168
23. Osadnik T, Strzelczyk J, Hawranek M, et al. Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease. BMC Cardiovasc Disord. 2013 ; 13: 113
24. Nabais S, Losa N, Gaspar A, et al. Association between red blood cell distribution width and outcomes at six months in patients with acute coronary syndromes. Rev Port Cardiol. 2009 ; 28 (9). 905-924
25. Lippi G, Filippozzi L, Montagnana M, et al. Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes. Clin Chem Lab Med. 2009 ; 47 (3). 353-357
26. Uyarel H, Ergelen M, Cicek G, et al. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis. 2011 ; 22 (3). 138-144
27. Dabbah S, Hammerman H, Markiewicz W, Aronson D. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol. 2010 ; 105 (3). 312-317
28. Fatemi O, Paranilam J, Rainow A, et al. Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention. J Thromb Thrombolys. 2013 ; 35 (1). 57-64
29. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American college of cardiology/American heart association task force on practice guidelines (committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004 ; 44 (3). E1 - E211
30. Sami S, Willerson JT. Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2). Tex Heart Inst J. 2010 ; 37 (3). 262-275
31. Laskey WK, Jenkins C, Selzer F, et al. NHLBI dynamic registry investigators. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol. 2007 ; 50 (7). 584-590
32. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999 ; 130 (6). 461-470
33. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two dimensional echocardiography. American society of echocardiography committee on standards, Subcommittee on quantitation of two- dimensional echocardiograms [review]. J Am Soc Echocardiogr. 1989 ; 2 (5). 358-367
34. Anderson JL, Adams CD, Antman EM, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation. 2013 ; 127 (23). e663 - e828
35. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 ; 127 (4). e362 - e425
36. Stolker JM, McCullough PA, Rao S, et al. Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography. J Am Coll Cardiol. 2010 ; 55 (14). 1433-1440
37. Kadri Z, Danchin N, Vaur L, et al. USIC 2000 Investigators. Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study. Heart. 2006 ; 92 (7). 910-915
38. Patti G, Ricottini E, Nusca A, et al. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty - contrast-induced nephropathy] trial. Am J Cardiol. 2011 ; 108 (1). 1-7
39. Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS study (protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome). J Am Coll Cardiol. 2014 ; 63 (1). 71-79
40. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005 ; 352 (10). 1011-1023
41. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009 ; 133 (4). 628-632
42. Fornal M, Wizner B, Cwynar M, et al. Association of red blood cell distribution width, inflammation markers and morphological as well as rheological erythrocyte parameters with target organ damage in hypertension. Clin Hemorheol Microcirc. 2014 ; 56 (4). 325-335
43. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients. Scand J Clin Lab Invest. 2008 ; 68 (8). 745-748
44. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009 ; 169 (5). 515-523
45. Yeun JY, Kaysen GA. C-reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD. Curr Opin Nephrol Hypertens. 2000 ; 9 (6). 621-630
46. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004 ; 266 (1-2). 37-56
47. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005 ; 68 (1). 14-22
48. Pflueger A, Abramowitz D, Calvin AD. Role of oxidative stress in contrast-induced acute kidney injury in diabetes mellitus. Med Sci Monit. 2009 ; 15 (6). RA125 - RA136
49. Akin F, Köse N, Ayça B, et al. Relation between red cell distribution width and severity of coronary artery disease in patients with acute myocardial infarction. Angiology. 2013 ; 64 (8). 592-596
50. Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC Jr. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol. 1990 ; 258 (1 pt 2). F115 - F120
51. Katholi RE, Woods WT Jr, Taylor GJ, et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis. 1998 ; 32 (1). 64-71
52. Tozzi-Ciancarelli MG, Di Giulio A, Troiani-Sevi E, D'Alfonso A, Amicosante G, Oratore A. Human erythrocyte damage at the initial stages of oxidative stress. Cell Biophys. 1989 ; 15 (3). 225-234
53. Marinkovic D, Zhang X, Yalcin S, et al. Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J Clin Invest. 2007 ; 117 (8). 2133-2144
54. Friedman JS, Lopez MF, Fleming MD, et al. SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood. 2004 ; 104 (8). 2565-2573
55. Wang T, Zhang X, Li JJ. The role of NF-kappa B in the regulation of cell stress responses. Int Immunopharmacol. 2002 ; 2 (11). 1509-1520